Kaya Holdings, Inc. (KAYS)

↓ Download CSV

CIK 0001530746 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2024, Kaya Holdings, Inc. reported revenue of $7.1K, down 96.4% from the prior year. The company ran a net loss, with a net margin of -29168.2% and a gross margin of -5.1%. It held $216.4K in total assets against $17.34M in total liabilities.

Key ratios (FY2024)

-5.1%
Gross margin
-28343.5%
Operating margin
-29168.2%
Net margin
-96.4%
Revenue growth (YoY)
Metric (FY)2024202320222021202020192018201720162015
Revenue$7.1K$196.3K$685.4K$889.9K$1.03M$1.01M
Cost of Revenue$7.5K$81.3K$225.1K$279.3K$310.7K
Gross Profit-$366$114.9K$460.3K$610.6K$718.9K$604.0K$642.5K$572.0K$399.6K$179.4K
Operating Income-$2.02M-$1.02M-$1.71M-$1.43M-$1.84M-$2.26M-$2.87M-$1.99M-$1.76M-$1.51M
Net Income-$2.08M$1.61M-$3.58M$9.72M-$12.30M$7.52M$4.54M-$15.09M-$20.20M-$3.23M
EPS (Diluted)$-0.07$0.01$-0.92$0.02$0.01$-0.12
Total Assets$216.4K$215.9K$843.2K$1.57M$2.30M$2.65M$2.64M$1.44M$710.4K$464.9K
Total Liabilities$17.34M$15.97M$18.45M$15.98M$27.22M$16.15M$25.95M$33.84M$21.70M$5.42M
Shareholders' Equity-$15.03M-$13.80M-$17.60M-$14.41M-$23.40M-$13.49M-$23.31M-$32.40M-$20.99M-$4.96M
Cash & Equivalents$29.1K$18.3K$566.0K$43.2K$87.0K$111.5K$318.5K$306.9K$123.9K
Operating Cash Flow-$830.8K-$1.18M-$918.8K-$1.04M-$289.6K-$774.9K-$1.33M-$2.21M-$1.09M-$733.5K
Capital Expenditures$27.1K$11.7K
Shares Outstanding41.46M22.16M22.17M14.72M14.26M12.50M165.81M138.99M117.08M88.86M